Brian Coe's most recent trade in Talis Biomedical Corp was a trade of 21,568 Series C-1 Preferred Stock done . Disclosure was reported to the exchange on Feb. 17, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Talis Biomedical Corp | Brian Coe | Director, Chief Executive Officer | 17 Feb 2021 | 21,568 | 0 | - | - | Series C-1 Preferred Stock | ||
| Talis Biomedical Corp | Brian Coe | Director, Chief Executive Officer | 17 Feb 2021 | 15,082 | 17,637 | - | - | Common Stock | ||
| Talis Biomedical Corp | Brian Coe | Director, Chief Executive Officer | 17 Feb 2021 | 12,035 | 0 | - | - | Series E-1 Preferred Stock | ||
| Talis Biomedical Corp | Brian Coe | Director, Chief Executive Officer | 17 Feb 2021 | 10,630 | 0 | - | - | Series F-1 Preferred Stock | ||
| Talis Biomedical Corp | Brian Coe | Director, Chief Executive Officer | 17 Feb 2021 | 8,416 | 26,053 | - | - | Common Stock | ||
| Talis Biomedical Corp | Brian Coe | Director, Chief Executive Officer | 17 Feb 2021 | 7,433 | 33,486 | - | - | Common Stock |